Your browser doesn't support javascript.
loading
A bi-steric mTORC1-selective inhibitor overcomes drug resistance in breast cancer.
Meng, Delong; Zhao, Xin; Yang, Yu Chi; Navickas, Albertas; Helland, Ciara; Goodarzi, Hani; Singh, Mallika; Bandyopadhyay, Sourav.
Afiliación
  • Meng D; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.
  • Zhao X; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.
  • Yang YC; Department of Biology, Revolution Medicines Inc., Redwood City, CA, USA.
  • Navickas A; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, 94158, USA.
  • Helland C; Department of Urology, University of California, San Francisco, San Francisco, CA, USA.
  • Goodarzi H; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
  • Singh M; Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, USA.
  • Bandyopadhyay S; Institut Curie, PSL Research University, CNRS UMR3348, INSERM U1278, Orsay, France.
Oncogene ; 42(28): 2207-2217, 2023 Jul.
Article en En | MEDLINE | ID: mdl-37264081
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Límite: Female / Humans Idioma: En Revista: Oncogene Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Límite: Female / Humans Idioma: En Revista: Oncogene Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos